Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia

Autoimmunity Reviews

Volumn 7, Issue 6, 2008, Pages 468-472

  Perotti, Mario ^a   Ghidoli, Nadia ^a   Altara, Raffaele ^a   Diotti, Roberta A ^a   Clementi, Nicola ^a   De Marco, Donata ^a   Sassi, Monica ^a   Clementi, Massimo ^a   Burioni, Roberto ^a   Mancini, Nicasio ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Autoimmunity; Cryoglobulinemia; HCV; Lymphoma

Indexed keywords

CRYOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLONE; CRYOGLOBULINEMIA; CRYOPRECIPITATE; GENE EXPRESSION; GENE OVEREXPRESSION; GERM LINE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK PATIENT; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN GENE; IMMUNOSTIMULATION; PHAGE DISPLAY; REVIEW;

AUTOANTIBODIES; CLONING, MOLECULAR; CRYOGLOBULINEMIA; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN M; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS;

EID: 51749089040     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.03.008     Document Type: Review

References (21)

1. Monti G., Pioltelli P., Saccardo F., Campanini M., Candela M., Cavallero G., et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 165 (2005) 101-105
2. Agnello V. The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection. Scand J Immunol 42 (1995) 179-184
3. Ferri S., Dal Pero F., Bortoletto G., Bianchi F.B., Lenzi M., Alberti A., et al. Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia. J Viral Hepatitis 13 (2006) 166-176
4. Saadoun D., Resche-Rigon M., Thibault V., Piette J.C., and Cacoub P. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term follow up study. Arthritis Rheum 54 (2006) 3696-3706
5. Landau D.A., Saadoun D., Calabrese L.H., and Cacoub P. The pathophysiology of HCV induced B-cell clonal disorders. Autoimmun Rev 6 (2007) 581-587
6. Carbonari M., Caprini E., Tedesco T., Mazzetta F., Tocco V., Casato M., et al. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis. J Immunol 174 (2005) 6532-6539
7. Chan C.H., Hadlock K.G., Foung S.K., and Levy S. VH1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen. Blood 97 (2001) 1023-1026
8. De Re V., De Vita S., Marzotto A., Rupolo M., Gloghini A., Pivetta B., et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 96 (2000) 3578-3584
9. Bugli F., Mancini N., Kang C.Y., Di Campli C., Grieco A., Manzin A., et al. Mapping B cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol 75 (2001) 9986-9990
10. Burioni R., Bugli F., Mancini N., Rosa D., Di Campli C., Moroncini G., et al. Non-neutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant fabs. Virology 288 (2001) 29-35
11. Burioni R., Mancini N., Carletti S., Perotti M., Grieco A., Canducci F., et al. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection. Virology 327 (2004) 242-248
12. Burioni R., Matsuura Y., Mancini N., Tani H., Miyamura T., Varaldo P.E., et al. Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype. J Virol 76 (2002) 11775-11779
13. Burioni R., Plaisant P., Manzin A., Rosa D., Delli Carri V., Bugli F., et al. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology 28 (1998) 810-814
14. Perotti M., Mancini N., Diotti R.A., Tarr A.W., Ball J.K., Owsianka A., et al. Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein. J Virol 82 (2008) 1047-1052
15. Barbas C.F., Bjorling E., Chiodi F., Dunlop N., Cababa D., Jones T.M., et al. Recombinant human Fabs neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci U S A 89 (1992) 9339-9343
16. Ferri C., Antonelli A., Mascia M.T., Sebastiani M., Fallahi P., Ferrari D., et al. HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 39 Suppl 1 (2007) S13-S21
17. Ferri C., Antonelli A., Mascia M.T., Sebastiani M., Fallahi P., Ferrari D., et al. B-cells and mixed cryoglobulinemia. Autoimmun Rev 7 (2007) 114-120
18. Saadoun D., Landau D.A., Calabrese L.H., and Cacoub P.P. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology 46 (2007) 1234-1242
19. Zignego A.L., Giannini C., and Ferri C. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol 13 (2007) 2467-2478
20. Simula M.P., Caggiari L., Gloghini A., and De Re V. HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens. Ann N Y Acad Sci 1110 (2007) 121-130
21. De Re V., Sansonno D., Simula M.P., Caggiari L., Gasparotto D., Fabris M., et al. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia 20 (2006) 1145-1154